Evidence map›Paper›PMID 39996130›Full record

ReviewNeurology. Genetics2025

The Neurodegenerative Disease Knowledge Portal: Propelling Discovery Through the Sharing of Neurodegenerative Disease Genomic Resources.

Allison A Dilliott, Maria C Costanzo, Sara Bandres-Ciga, Cornelis Blauwendraat, Bradford Casey, Quy Hoang, Hirotaka Iwaki, Dongkeun Jang, Jonggeol Jeffrey Kim, Hampton L Leonard and 12 more

Erratum issuedAbstract readReview
In one paragraph

Review in Neurology. Genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Allison A DilliottDepartment of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0003-3863-9304
Maria C CostanzoPrograms in Metabolism and Medical and Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, MA.
Sara Bandres-CigaCenter for Alzheimer's and Related Dementias, NIH, Bethesda, MD.
Cornelis BlauwendraatCenter for Alzheimer's and Related Dementias, NIH, Bethesda, MD.
Bradford CaseyMichael J. Fox Foundation for Parkinson's Research, New York, NY.
Quy HoangPrograms in Metabolism and Medical and Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, MA.
Hirotaka IwakiCenter for Alzheimer's and Related Dementias, NIH, Bethesda, MD.
Dongkeun JangPrograms in Metabolism and Medical and Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, MA.
Jonggeol Jeffrey KimCenter for Alzheimer's and Related Dementias, NIH, Bethesda, MD.
Hampton L LeonardCenter for Alzheimer's and Related Dementias, NIH, Bethesda, MD.ORCID https://orcid.org/0000-0003-2390-8110
Kristin S LevineCenter for Alzheimer's and Related Dementias, NIH, Bethesda, MD.
Mary MakariousCenter for Alzheimer's and Related Dementias, NIH, Bethesda, MD.ORCID https://orcid.org/0000-0002-7978-1051
Trang T NguyenPrograms in Metabolism and Medical and Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, MA.
Guy A RouleauDepartment of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0001-8403-1418
Andrew B SingletonCenter for Alzheimer's and Related Dementias, NIH, Bethesda, MD.ORCID https://orcid.org/0000-0001-5606-700X
Patrick SmadbeckPrograms in Metabolism and Medical and Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, MA.
J SolleMichael J. Fox Foundation for Parkinson's Research, New York, NY.ORCID https://orcid.org/0000-0002-9941-4830
Dan VitaleCenter for Alzheimer's and Related Dementias, NIH, Bethesda, MD.
Mike NallsCenter for Alzheimer's and Related Dementias, NIH, Bethesda, MD.
Jason FlannickPrograms in Metabolism and Medical and Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, MA.
Noël P BurttPrograms in Metabolism and Medical and Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, MA.
Sali M K FarhanDepartment of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0001-5936-0957

Funding

The Association to Function Knowledge Portal: a genomic data resource for translating GWAS associations to biological effectsU24HG011453 · NHGRI · BROAD INSTITUTE, INC. · PI BURTT, NOEL P, FLANNICK, JASON · 2021 to 2025
$3.4M
NHGRI NIH HHS U24 HG011453
6 · The paper itself

Abstract

Although large-scale genetic association studies have proven useful for the delineation of neurodegenerative disease processes, we still lack a full understanding of the pathologic mechanisms of these diseases, resulting in few appropriate treatment options and diagnostic challenges. To mitigate these gaps, the Neurodegenerative Disease Knowledge Portal (NDKP) was created as an open-science initiative with the aim to aggregate, enable analysis, and display all available genomic datasets of neurodegenerative disease, while protecting the integrity and confidentiality of the underlying datasets. The portal contains 218 genomic datasets, including genotyping and sequencing studies, of individuals across 10 different phenotypic groups, including neurologic conditions such as Alzheimer disease, amyotrophic lateral sclerosis, Lewy body dementia, and Parkinson disease. In addition to securely hosting large genomic datasets, the NDKP provides accessible workflows and tools to effectively use the datasets and assist in the facilitation of customized genomic analyses. Here, we summarize the genomic datasets currently included within the portal, the bioinformatics processing of the datasets, and the variety of phenotypes captured. We also present example use cases of the various user interfaces and integrated analytic tools to demonstrate their extensive utility in enabling the extraction of high-quality results at the source, for both genomics experts and those in other disciplines. Overall, the NDKP promotes open science and collaboration, maximizing the potential for discovery from the large-scale datasets researchers and consortia are expending immense resources to produce and resulting in reproducible conclusions to improve diagnostic and therapeutic care for patients with neurodegenerative disease.

Identifiers

PMID39996130
PMCPMC11849525

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.